cbdMD, Inc. (YCBD)

Market Cap	7.81M
Revenue (ttm)	19.59M
Net Income (ttm)	-4.16M
Shares Out	8.91M
EPS (ttm)	-6.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,765
Open	0.8200
Previous Close	0.8260
Day's Range	0.8200 - 0.8800
52-Week Range	0.7600 - 6.5380
Beta	2.43
Analysts	Strong Buy
Price Target	3.00 (+242.15%)
Earnings Date	Aug 13, 2025

About YCBD

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solution...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 42
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: YCBD
• Website: https://www.cbdmd.com

Financial Performance

In 2024, cbdMD's revenue was $19.48 million, a decrease of -19.35% compared to the previous year's $24.16 million. Losses were -$7.70 million, -71.40% less than in 2023.

Analyst Forecast

According to one analyst, the rating for YCBD stock is "Strong Buy" and the 12-month stock price forecast is $3.0.

Price Target

$3.0

(242.15% upside)

Analyst Consensus: Strong Buy